Pisetsky DS - Search Results

1

ICF core sets: how to specify impairment and function in systemic lupus erythematosus.

Aringer M, Stamm TA, Pisetsky DS, Yarboro CH, Cieza A, Smolen JS, Stucki G. Aringer M, et al. Among authors: pisetsky ds. Lupus. 2006;15(4):248-53. doi: 10.1191/0961203306lu2298xx. Lupus. 2006. PMID: 16686267 Free article.

2

The binding of sera of patients with SLE to bacterial and mammalian DNA.

Hamilton KJ, Schett G, Reich CF 3rd, Smolen JS, Pisetsky DS. Hamilton KJ, et al. Among authors: pisetsky ds. Clin Immunol. 2006 Feb-Mar;118(2-3):209-18. doi: 10.1016/j.clim.2005.10.009. Epub 2005 Nov 18. Clin Immunol. 2006. PMID: 16298553

3

Relevant concepts of functioning for patients with systemic lupus erythematosus identified in a Delphi exercise of experts and a literature review.

Leuchten N, Bauernfeind B, Kuttner J, Stamm T, Smolen JS, Pisetsky DS, Aringer M. Leuchten N, et al. Among authors: pisetsky ds. Arthritis Care Res (Hoboken). 2014 Dec;66(12):1895-904. doi: 10.1002/acr.22372. Arthritis Care Res (Hoboken). 2014. PMID: 24839085 Free article. Review.

4

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial.

Stamm TA, Machold KP, Aletaha D, Alasti F, Lipsky P, Pisetsky D, Landewe R, van der Heijde D, Sepriano A, Aringer M, Boumpas D, Burmester G, Cutolo M, Ebner W, Graninger W, Huizinga T, Schett G, Schulze-Koops H, Tak PP, Martin-Mola E, Breedveld F, Smolen J. Stamm TA, et al. Arthritis Res Ther. 2018 Aug 9;20(1):174. doi: 10.1186/s13075-018-1667-z. Arthritis Res Ther. 2018. PMID: 30092827 Free PMC article. Clinical Trial.

5

The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity.

Eudy AM, Reeve BB, Coles T, Lin L, Rogers JL, Pisetsky DS, Criscione-Schreiber LG, Doss J, Sadun R, Sun K, Clowse ME. Eudy AM, et al. Among authors: pisetsky ds. Lupus. 2022 May;31(6):697-705. doi: 10.1177/09612033221090885. Epub 2022 Mar 28. Lupus. 2022. PMID: 35343853 Free PMC article.

6

Systemic lupus erythematosus. Diagnosis and treatment.

Pisetsky DS, Gilkeson G, St Clair EW. Pisetsky DS, et al. Med Clin North Am. 1997 Jan;81(1):113-28. doi: 10.1016/s0025-7125(05)70507-1. Med Clin North Am. 1997. PMID: 9012757 Review.

7

B lymphocytes and systemic lupus erythematosus.

Criscione LG, Pisetsky DS. Criscione LG, et al. Among authors: pisetsky ds. Curr Rheumatol Rep. 2003 Aug;5(4):264-9. doi: 10.1007/s11926-003-0004-x. Curr Rheumatol Rep. 2003. PMID: 14531953 Review.

8

DNA as a marker of cell death in systemic lupus erythematosus.

Pisetsky DS. Pisetsky DS. Rheum Dis Clin North Am. 2004 Aug;30(3):575-87, x. doi: 10.1016/j.rdc.2004.04.009. Rheum Dis Clin North Am. 2004. PMID: 15261342 Review.

9

Systemic lupus erythematosus and related diseases.

Tran TT, Pisetsky DS. Tran TT, et al. Among authors: pisetsky ds. Autoimmunity. 2004 Jun;37(4):301-4. doi: 10.1080/08916930410001708698. Autoimmunity. 2004. PMID: 15518046 Review. No abstract available.

10

Antibodies to DNA: infection or genetics?

Pisetsky DS, Vrabie IA. Pisetsky DS, et al. Lupus. 2009 Nov;18(13):1176-80. doi: 10.1177/0961203309106492. Lupus. 2009. PMID: 19880564 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

438 results

Search Page